Doctify, the medical care review platform, has received a $10m (£8.1m) funding boost to continue its international growth and expand its team.
London-based Doctify was founded by two trainee surgeons after they encountered a concerning lack of reliable and transparent online reviews for medical professionals.
The founders drew inspiration from TripAdvisor and Glassdoor, which have allowed job seekers and tourists to make informed decisions based on other people’s experiences.
“Our health is the most precious thing we have. With Doctify, we are working on building the world’s most important healthcare platform to help millions of patients,” said Stephanie Eltz, CEO and co-founder of Doctify.
It was launched to fill the healthcare gap in the user review industry and, according to the company, has since been used by more than 50 million patients in the UK and across its international markets of Germany, Austria, UAE, and Australia.
The funding round was led by Beringea and featured participation from existing investors, including Keen Venture Partners, Amadeus Capital Partners, and Guinness Ventures.
“With referrals, we trust our GP or friends and family when really, that is just a single opinion. Many insurers make referrals to doctors who have the best rates,” said Carrie Babcock, investment manager at Beringea.
“Doctify is solving the healthcare journey through patient reviews but also by publishing professional endorsements between doctors.”
Babcock added: “It makes no sense that consumers remain in the dark about healthcare providers, while they can find thousands of reviews for a holiday rental!”
With the latest addition, Doctify has now raised more than £22m since its launch in 2015. The company’s last funding round was in April 2021, when it raised $7.5m (£6m).